Study identifies perception gap in incidence, impact of CINV/RINV

the ONA take:

There is a perpetual gap between healthcare professionals and patient perceptions of incidence and impact on patients' daily life of chemotherapy- and radiotherapy-induced nausea and vomiting (CINV/RINV), according to findings presented at the joint Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO) 2015 Annual Meeting on Supportive Care in Cancer in Copenhagen, Denmark.

Researchers found that oncologists and oncology nurses overestimate the incidence of CINV/RINV, but underestimate the effect that CINV/RINV has on patients' daily lives. Moreover, data showed that 28% of patients believe oncologists underestimate the impact of CINV/RINV on patients' daily lives.

Results also showed that physicians and nurses believe 60% of patients are fully compliant with physicians' and/or nurses guidelines for self-administration of anti-emetic medications; however, only 38% reported full compliance. Patients reported reluctance to increase pill burden and concern that swallowing would cause nausea/vomiting as reasons for non-compliance.

The findings suggest that the gap between physician and patient perceptions may result in inadequate management of patients' CINV/RINV.

Study identifies perception gap in incidence, impact of CINV/RINV
There is a perpetual gap between healthcare professionals and patient perceptions of incidence and impact on patients' daily life of CINV/RINV.
Norgine B.V. has presented new data highlighting a perceptual gap between healthcare professionals and patients in terms of the incidence and impact on patients' daily life of chemotherapy and radiotherapy induced nausea and vomiting.
READ FULL ARTICLE From Medical News Today
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs